International conference on Biomolecules and Nanosciences October 16-17, 2018 Ottawa, Ontario, Canada

Amalia A Vartanian, PhD, DSci, is senior principle scientist at the N.N. Blokhin Russian Cancer Research Center. Dr Vartanian grew up in Armenia and graduated Yerevan State University in 1979. She obtained a PhD in molecular biology from Engelghardt Institute of Molecular Biology, Moscow, Russia in 1986. Prior to taking the position at the Russian Cancer Research Center she did research in cancer cell biology in Liverpool, UK, Autchus, Demark, Verona, Italy and Engelghardt Institute of Molecular Biology, Moscow, Russia. The research of her team is focused on studying the molecular mechanisms involved in tumor vascularization. Dr Vartanian obtained a DSci in cancer cell biology from Russian Cancer Research Center in 2012. Dr Vartanian is an expert in the research area of cancer cell biology, target identification, drug resistance and cancer biomarkers. Dr Vartanian was selected to the European Association for Cancer Research in 2010.

Cancer, Cell biology, Molecular biology, Biomarkers.

Dr. Dilip Kumar Bhattacharya, obtained his M. Sc., & Ph.D. degree from the department of Pure Mathematics, University of Calcutta. He is a Fellow of International Academy of Physical Sciences. His teaching experience is 52 years. He started teaching in different Govt. colleges including Presidency College, Calcutta, from 1966 and joined the department of Pure mathematics, Calcutta University in the year 1980. He retired from the department as Prof. & Head in the year 2008. He acted as AICTE Emeritus professor in school of Bioscience & Engineering in Jadavpur University from 2009-2011 and as UGC Emeritus professor in the department of Instrumental Music, Rabindra Bharati University from 2011-2013. He acted as Guest professor (2005-2008) in Biostatistics and Biomathematics - School of Bioscience and Engineering – Jadavpur University; Guest professor (2008) in Bio-informatics – DOEACC Center, (an autonomous Society under Ministry of Communications and Information technology, Govt. of India) at Jadavpur University ; Guest professor (2008-2013) in Mathematics - Department of Mathematics, Rabindra Bharati University; Guest professor (2013 -2015) in Bioinformatics- Narula Institute of Technology, Kolkata. He is continuing as guest professor in Post-graduate departments of different colleges. His U.G.C. Project was ‘Analytical study on role of music in psychosomatic stress management’.

His areas of Research are : (i) Functional Analysis - Banach algebra, extension and allied problems. (ii) Complex Analysis- Space of entire Dirichlet Series (iii) Differential Geometry- Abstraction of Differentiable manifold. (iv)Differential Equation-Mathematical modeling and Qualitative theory of ordinary differential equation and its applications in Biology and medicine. (v) Nonlinear Optimization (vi)Vector optimization of functions in abstract spaces (vii)Control theoretic optimization of functionals and their vector generalization (a)Optimal control of single objective, multi-objective and fractional objective control problems with restrictions in the parameter domain (with or without delay) with applications in Biology [including Fishery Biology, Marine Biology, Integrated Pest management problem under release of Sterile Insect and immigration from outside the control area, bacterial and viral infections; vertical and horizontal transmission of diseases, atmospheric pollution and in Inventory control problem]. (b)Optimal control of single objective, multi-objective and fractional objective control problems with restrictions in the parameter domain as well as in the state space and their applications in realistic problems, including the state space as a manifold with boundary

Miles is General Manager at Golden Biotechnology Corporation, Taiwan. In this role, he is responsible for the discovery and selection of new drugs for development and the overall strategic planning of GBC`s business. In this position, he exerted himself to understand the MoA of a natural small molecule named Antroquinonol. Antroquinonol is a NME with demonstrated anti-cancer, liver protection, immune-modulatory, and anti-inflammatory effects. Phase I trial showed low toxicity profile with no treatment-related deaths and serious adverse events among NSCLC patients refractory to conventional treatments. Antroquinonol has been granted Orphan Drug Status by the FDA and European Commission for the treatment of pancreatic cancer, AML, and HCC. Its postulated mechanism of action for isoprenyltransferase inhibitor in turn blocks the necessary post-translational modifications of RAS and RAS-related proteins responsible for cancer cell proliferation. The Nrf2 activator and NF-B inhibitor roles of Antroquinonol were also be demonstrated in vivo. Miles graduated with a PhD in Graduate Institute of Biotechnology from National Chung Hsing University Taiwan, and completed his postdoctoral research at the Academia Sinica Taiwan.

He exerted himself to understand the MoA of a natural small molecule named Antroquinonol.

With 33 years of clinical laboratory experience, Patty Eschliman, has worked in several different settings. From a third shift generalist, to an HLA Tissue Typing Tech, to supervising Flow Cytometry and; for the past 23 years, laboratory management. An active member of the Clinical Laboratory Management Association (CLMA) since 1997, Patty has held leadership positions within the Nebraska and Western Iowa Great Plains Chapter, was elected to the International Board of Directors in 2009 and served as President from 2015 - 2017. Fulfilling the CLMA seat on the American Society for Clinical Pathology (ASCP) Board of Governors, Board of Certification, Patty volunteers on the Executive Committee, Finance Committee, and is the Board Liaison to the Laboratory Management Exam (DLM). In 2013, Patty completed her Masters in Healthcare Administration and as of December 2017 is now a Certified Professional Coach, specializing in Laboratory Leadership – helping scientists reach their full potential.

Energy Leadership

Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, Suchkov graduated from Astrakhan State Medical University and was awarded with MD. During the studentship Suchkov was extensively involved into research in the area of ocular immunology and won in 1980 the First Prize at the First International Contest among the Medical Students in Praque. In 1985, Suchkov maintained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Academy of Medical Sciences, Moscow, Rus-sia. In 2001, Suchkov finished the PostDoc Research Fellowship Program and maintained his Doctor Degree at the National Institute of Immunology, Russia. From 1985 through 1987, Dr Suchkov worked as a Post Doc Research Associate, Department of Medi-cal Biotechnology, Institute of Medical Enzymology, USSR Academy of Medical Sciences to be in-volved into research in clinical enzymology and applications of DNA-dependent enzymes in clinical medicine. From 1987 through 1989, Dr Suchkov was a senior Researcher, Lab of Developmental Immunology, Koltzov Institute of Developmental Biology, USSR Academy of Sciences to deal to developmental immunology. From 1989 through 1995, Dr Suchkov was being a Head of the Lab of Clinical Immunology and Im-munobiotechnology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004, Dr Suchkov was being a Chairman of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI) and the Immunologist-in-Chief of the Moscow Regional Ministry of Health. Dr Suchkov has been trained at: ● Lab of Immunology, NEI, Bethesda, MD, USA,, NIH and Lab of Immunology; ● Wills Eye Hospital, Philadelphia, USA; ● University of Florida in Gainesville; ● University of California in S-F (UCSF), USA ● Center for Autoimmunity Research, Johns Hopkins University, Baltimore, MD, USA as well as at some of the British and Swedish Universities on the invitation of the Royal Society for Immunology and Karolinska Academy, respectively; In 1993-1996, Dr Suchkov was an Executice Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov, M, PhD, is: ● Professor in Immunology and Medicine, ● Director, Center for Personalized Medicine and Professor, Department of Pathology, School for Pharmacy, Sechenov University, ● Chair, Department for Translational Medicine, Moscow Engineering Physical Institute (MEPhI), ● Professor, Dept for Immunology, School of Medicine, A.I.Evdokimov Moscow State University of Medicine & Dentistry, Moscow, Russia ● Member, New York Academy of Sciences, NY, USA ● Secretary General, UCC (United Cultural Convention), Cambridge, UK. Dr Suchkov has been collaborating with scientists from USA, Japan, Germany, Israel and other coun-tries to set up a new brand in the modern medicine, i.e., PPM. In 1991-1998, Dr Suchkov is a Co-Supervisor over the Russian-American Agreement on scientific and clinical collaboration in the field of ocular immunology between Russian Academy of Sciences and National Institutes of Health (NIH); in 1991-1995 – a member of The Reciprocal Exchange Fellowship Program between Russian Immunological Society and British Society for Immunology.

Immunology and Medicine

'PhD in Organic Synthesis of Natural Products from the University of Alberta, Edmonton. Postdoctoral work at the Institut de Chimie des Substances Naturelles, Gif sur Yvette, France. Specialized on Medicinal Chemistry and EcoHealth, with strong emphasis on controlling vector insects, without pesticides, by educating people on the life cycle of the insects and empowering them with the responsibility of caring for their surrounding environment. One example, is the creation and implementation of the ‘ovillanta’, a piece of a recycled tire to enhance the attraction of natural chemical lures, to a tremendous success. This allows for the recycling and elimination of tires, which produce mosquitoes, putting those tire pieces to destroy the same insects. Profiting from our continuous traveling through the region, we are developing other projects with local farmers, giving added value to their agricultural residues and identifying, extracting compounds of pharmaceutical value. One example, we are educating people on the extraction and purification of mangiferin from waste mango leaves and peel. '

Organic Synthesis of Natural Products